Introduction

 

Bladder cancer is a well-known condition that affects men more often than women. The disease will be the fourth most commonly diagnosed form of cancer in men in the United States in 2010. According to the American Cancer Society, the chance of a man having this cancer is about 1 in 27, or 70,530 new estimated cases. For women, it is 1 in 85. Bladder cancer overwhelmingly occurs in those over 55 years old.

Your bladder is a hollow organ in the lower part of your abdomen that collects liquid waste (urine) and stores it until the urine is ready to exit your body. Bladder cancer develops when a part of the bladder rapidly produces too many cells. These cells show out-of-control growth and can become cancer. Most bladder cancer forms on the walls of the organ.

Other names for cancer of the bladder are bladder carcinoma (carcinoma of the bladder) and adenocarcinoma of the bladder. "Carcinoma" means cancer of the cells that make up linings within organs. "Adenocarcinoma" means cancer of the glandular structures within many organs, including the bladder. Glandular structures normally release substances important to body well-being.

The exact cause of bladder cancer is not known. The most important risk factor for bladder cancer is believed to be smoking. Smoking causes about half of the deaths from bladder cancer in men and more than one-third of bladder cancer deaths in women. Other risk factors for bladder cancer include a family history of bladder cancer, exposure to certain chemicals, having a long-term bladder infection or other irritation, and older age.

This content was last reviewed August 15, 2010 by Dr. Reshma L. Mahtani.
Latest Bladder Cancer News
Arsenic cancer risk still high decades later

January 24, 2012 — NEW YORK (Reuters Health) - People exposed to very high levels of arsenic in Chilean drinking water back in the 1950s and 60s are still showing a higher-than-normal risk of bladder cancer -- years after the arsenic problem was brought under control, a new study shows.

Not enough evidence for bladder cancer screening

August 16, 2011 — NEW YORK (Reuters Health) - There is not enough evidence to support routine screening tests for bladder cancer, according to new U.S. recommendations.

EU agency calls for new warnings on Takeda's Actos

July 21, 2011 — LONDON (Reuters) - Takeda Pharmaceutical's diabetes pill Actos should carry new warnings about its possible link to bladder cancer, Europe's drug regulator said on Thursday, following a safety review of the medicine.

Select news items provided by Reuters Health